Anna González-Neira was born in London in 1971 and studied at the Universidad Complutense de Madrid where she graduated in Biology in 1995. In 1996 she joined the Faculty of Medicine, the Universidad de Santiago de Compostela (Spain), where she obtained her PhD degree in Medicine under the supervision of A. Carracedo for which she was awarded the Thesis Prize.
During this period she was also a Research Fellow at the Office of the Chief Medical Examiner, Department of Forensic Biology, New York University Medical Centre (USA) and at the Institute of Pathology and Molecular Immunology (IPATIMUP), Universidade do Porto, Portugal.
She spent three years as a Postdoctoral Fellow at the Unit of Evolutionary Biology, Universidad Pompeu Fabra in Barcelona under the supervision of J. Bertranpetit. She has also held fellowships at the Welcome Trust Sanger Institute, Cambridge (UK) in the groups of I. Dunham and P. Deloukas and later moved to Oxford (UK) to work at the Department of Bioinformatics and Statistical Genetics, Welcome Centre of Human Genetics, supervised by L. Cardon.
Anna joined the CNIO in September 2004 to head the Human Genotyping Core Unit.
Her current research focuses on the identification of genetic factors associated with efficacy and toxicity of anticancer drugs.